Isomorphic Labs was spun out of Google DeepMind, after the tech giant achieved one of the biggest biological breakthroughs in the last 50 years. Demis Hassabis is at the helm of both Isomorphic and ...
Alphabet’s drug discovery arm, Isomorphic Labs, is preparing to enter a new chapter in its ambitious efforts to reshape medicine through artificial intelligence, with its first human clinical trials ...
The company will build on research carried out by London artificial intelligence lab DeepMind, which Google acquired in 2014. Demis Hassabis, the CEO and co-founder of DeepMind, is the founder and CEO ...
Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at ...
Isomorphic Labs to Receive $45 Million in Upfront Payment with Potential Total Deal Value up to $1.7 Billion LONDON, Jan. 7, 2024 /PRNewswire/ -- Isomorphic Labs, a digital biology company with a ...
MASTERING HEALTHCARE MANAGEMENT JUST IN 7 DAYS: Command HR Leadership And Scalable Strategies To Ensure Your Hospital Runs Smoothly Without You Isomorphic Labs, a drug discovery company spun out of ...
Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...
On a rare sunny day in London at the Google DeepMind office, Colin Murdoch saw the bank deposit from his employer come through. It wasn't his paycheck. Google was investing in his startup. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results